MICHAEL E RYTTING to DNA, Neoplasm
This is a "connection" page, showing publications MICHAEL E RYTTING has written about DNA, Neoplasm.
Connection Strength
0.029
-
Safety and clinical activity of 5-aza-2'-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia. Br J Haematol. 2014 Nov; 167(3):356-65.
Score: 0.020
-
Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia. Blood. 2004 Feb 01; 103(3):784-9.
Score: 0.009